Nora Majtanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nora Majtanova has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Juraj Majtan
Slovak Academy of Sciences
4 shared publications - Petr Kolar
Slovak Med Univ, Dept Ophthalmol, 11 Antolska St, Bratislava 85107, Slovakia
4 shared publications - Veronika Kurilova
Faculty of Electrical Engineering and Information Technology, Slovak University of Technology in Bratislava, 841 04 Bratislava, Slovakia
3 shared publications Adriana Takacova
Department of Ophthalmology, Slovak Medical University and University Hospital in Bratislava, Bratislava, Slovakia
2 shared publicationsAlexandra Sedlakova
Department of Ophthalmology, Jessenius Faculty of Medicine, Comenius University and University Hospital, Martin, Slovakia
2 shared publicationsBeata Busanyova
Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia
2 shared publications
Latest Publications
- 3 August 2026
- Published by Czech Society of Ophthalmology of the CzMA in Ceska a Slovenska Oftalmologie : Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti
Preserflo MicroShunt – A Modern Microinvasive Approach in the Surgical Treatment of Glaucoma. A Review
Preserflo MicroShunt (Santen Pharmaceutical, Osaka, Japan) is a new drainage implant designed for controlling intraocular pressure (IOP) in patients with open-angle glaucoma in cases where conservative therapy has failed. The implant, made of biocompatible SIBS material, drains aqueous humor from the anterior chamber to the sub-Tenon’s space, ensuring the long-term reduction of IOP. This review article summarizes the available clinical and experimental data on the Preserflo MicroShunt, compares its efficacy and safety to traditional trabeculectomy, and defines its role within the current glaucoma surgery algorithm.
- 3 August 2026
- Published by Czech Society of Ophthalmology of the CzMA in Ceska a Slovenska Oftalmologie : Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti
Preserflo MicroShunt – A Modern Microinvasive Approach in the Surgical Treatment of Glaucoma. A Review
Preserflo MicroShunt (Santen Pharmaceutical, Osaka, Japan) is a new drainage implant designed for controlling intraocular pressure (IOP) in patients with open-angle glaucoma in cases where conservative therapy has failed. The implant, made of biocompatible SIBS material, drains aqueous humor from the anterior chamber to the sub-Tenon’s space, ensuring the long-term reduction of IOP. This review article summarizes the available clinical and experimental data on the Preserflo MicroShunt, compares its efficacy and safety to traditional trabeculectomy, and defines its role within the current glaucoma surgery algorithm.
- Open Access
- 23 November 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (12) , 1192
Country-Specific Approaches to Preventing Infections in Cataract Surgery
Background/Objectives: Antimicrobial resistance (AMR) is a major global health threat. In patients undergoing cataract surgery, AMR complicates infection control, particularly efforts to reduce the risk of endophthalmitis—a rare but severe postoperative complication. This article reviews country-specific strategies for endophthalmitis prevention, focusing on antimicrobial use. Methods: Ophthalmology experts from 10 countries contributed national perspectives on infection prevention. Official guidelines served as the primary basis for analysis; when unavailable, expert opinion and routine clinical practice were considered. Results: Routine preoperative antibiotic use is uncommon in 6 out of 10 countries. Instead, artificial tears and bacteriostatic or bactericidal treatments are frequently employed. One country allows optional antibiotic use, while 3 include it in routine preoperative care. For intraoperative management, antisepsis with 5–10% povidone-iodine is standard practice in 9 countries. Intracameral cefuroxime (typically 1 mg/0.1 mL) is widely used in 7 countries and considered essential in most countries. Postoperatively, broad-spectrum topical antibiotics, primarily fluoroquinolones, are typically prescribed, often as fixed-dose combinations with corticosteroids (8 countries), although duration and regimens vary. Conclusions: Despite national differences, povidone-iodine, intracameral cefuroxime, and topical fluoroquinolones are widely used. Preoperative antibiotic use varies, while postoperative regimens are more consistent. These practices reflect local AMR patterns, regulations, and available healthcare resources. Although broad-spectrum agents are generally preferred, they raise concerns about resistance. Tailoring prophylactic strategies to local microbiological profiles and limiting the duration of antibiotic therapy are key to balancing efficacy and stewardship. An individualized, evidence-based approach is essential to reduce endophthalmitis risk and address AMR challenges.
- 23 November 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (12) , 1192
Open AccessCountry-Specific Approaches to Preventing Infections in Cataract Surgery
Background/Objectives: Antimicrobial resistance (AMR) is a major global health threat. In patients undergoing cataract surgery, AMR complicates infection control, particularly efforts to reduce the risk of endophthalmitis—a rare but severe postoperative complication. This article reviews country-specific strategies for endophthalmitis prevention, focusing on antimicrobial use. Methods: Ophthalmology experts from 10 countries contributed national perspectives on infection prevention. Official guidelines served as the primary basis for analysis; when unavailable, expert opinion and routine clinical practice were considered. Results: Routine preoperative antibiotic use is uncommon in 6 out of 10 countries. Instead, artificial tears and bacteriostatic or bactericidal treatments are frequently employed. One country allows optional antibiotic use, while 3 include it in routine preoperative care. For intraoperative management, antisepsis with 5–10% povidone-iodine is standard practice in 9 countries. Intracameral cefuroxime (typically 1 mg/0.1 mL) is widely used in 7 countries and considered essential in most countries. Postoperatively, broad-spectrum topical antibiotics, primarily fluoroquinolones, are typically prescribed, often as fixed-dose combinations with corticosteroids (8 countries), although duration and regimens vary. Conclusions: Despite national differences, povidone-iodine, intracameral cefuroxime, and topical fluoroquinolones are widely used. Preoperative antibiotic use varies, while postoperative regimens are more consistent. These practices reflect local AMR patterns, regulations, and available healthcare resources. Although broad-spectrum agents are generally preferred, they raise concerns about resistance. Tailoring prophylactic strategies to local microbiological profiles and limiting the duration of antibiotic therapy are key to balancing efficacy and stewardship. An individualized, evidence-based approach is essential to reduce endophthalmitis risk and address AMR challenges.
- Open Access
- 27 May 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (7) , 1571-1572
Author Correction: Economic Burden of Age-Related Macular Degeneration and Diabetic Macular Edema in Slovakia: a Cost-of-illness Analysis
- 27 May 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (7) , 1571-1572
Open AccessAuthor Correction: Economic Burden of Age-Related Macular Degeneration and Diabetic Macular Edema in Slovakia: a Cost-of-illness Analysis
- Open Access
- 15 April 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (4) , 544-551
Economic Burden of Age-Related Macular Degeneration and Diabetic Macular Edema in Slovakia: a Cost-of-illness Analysis
Background: Visual impairment and blindness significantly affect patient health and socioeconomic status. Among the main causes of vision impairment are Age-related Macular Degeneration (AMD) in both wet (neovascular) and dry (non-exudative) forms, and Diabetic Macular Edema (DME). These conditions represent major healthcare burdens due to associated medical and societal costs. Objective: The objective of the present study was to evaluate the economic burden of wet and dry AMD and DME in Slovakia, emphasizing direct medical and non-medical costs, as well as indirect costs due to lost productivity. Methods: A prevalence-based "cost-of-illness" strategy was applied retrospectively for the year 2021 from a societal perspective. Data were collected using structured questionnaires from patients and ophthalmologists, Slovak healthcare databases (National Centre for Health Information—NCZI), health insurance records, and patient advocacy groups. Bottom-up costing was applied to direct healthcare costs, establishing healthcare services and unit costs, whereas indirect costs were ascertained by the human capital approach. Non-medical costs were also extrapolated from patient surveys and consultant interviews. Results: For the year 2021, the total annual economic burden for wet AMD was approximately €105.7 million and for DME was €45.1 million in Slovakia. The total annual cost per patient was €5,281 for wet AMD and €4,049 for DME. Direct healthcare costs represented over half (54%) of wet AMD costs, predominantly due to pharmacotherapy (€23.9 million) and hospital/emergency care (€13.7 million). For DME, direct care consisted of approximately 36% (€16.0 million), with pharmacotherapy (€6.2 million) and treatment monitoring and management (€2.5 million each) as the leaders. Non-medical direct spending (transport, home adaptation) was negligible for both conditions (13% wet AMD, 2% DME). Indirect costs like absenteeism, presenteeism, and formal care accounted for 33% of wet AMD and over 60% of the cost of DME. Specifically, presenteeism was the largest share in indirect costs in DME (€16.1 million). Conclusion: Wet AMD and DME impose tremendous economic loads on the Slovak healthcare system and society, which are predominantly driven by direct medical and indirect productivity costs. Effective prevention, early diagnosis, and optimal management strategies would significantly reduce these economic loads and improve patient outcomes.
- 15 April 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (4) , 544-551
Open AccessEconomic Burden of Age-Related Macular Degeneration and Diabetic Macular Edema in Slovakia: a Cost-of-illness Analysis
Background: Visual impairment and blindness significantly affect patient health and socioeconomic status. Among the main causes of vision impairment are Age-related Macular Degeneration (AMD) in both wet (neovascular) and dry (non-exudative) forms, and Diabetic Macular Edema (DME). These conditions represent major healthcare burdens due to associated medical and societal costs. Objective: The objective of the present study was to evaluate the economic burden of wet and dry AMD and DME in Slovakia, emphasizing direct medical and non-medical costs, as well as indirect costs due to lost productivity. Methods: A prevalence-based "cost-of-illness" strategy was applied retrospectively for the year 2021 from a societal perspective. Data were collected using structured questionnaires from patients and ophthalmologists, Slovak healthcare databases (National Centre for Health Information—NCZI), health insurance records, and patient advocacy groups. Bottom-up costing was applied to direct healthcare costs, establishing healthcare services and unit costs, whereas indirect costs were ascertained by the human capital approach. Non-medical costs were also extrapolated from patient surveys and consultant interviews. Results: For the year 2021, the total annual economic burden for wet AMD was approximately €105.7 million and for DME was €45.1 million in Slovakia. The total annual cost per patient was €5,281 for wet AMD and €4,049 for DME. Direct healthcare costs represented over half (54%) of wet AMD costs, predominantly due to pharmacotherapy (€23.9 million) and hospital/emergency care (€13.7 million). For DME, direct care consisted of approximately 36% (€16.0 million), with pharmacotherapy (€6.2 million) and treatment monitoring and management (€2.5 million each) as the leaders. Non-medical direct spending (transport, home adaptation) was negligible for both conditions (13% wet AMD, 2% DME). Indirect costs like absenteeism, presenteeism, and formal care accounted for 33% of wet AMD and over 60% of the cost of DME. Specifically, presenteeism was the largest share in indirect costs in DME (€16.1 million). Conclusion: Wet AMD and DME impose tremendous economic loads on the Slovak healthcare system and society, which are predominantly driven by direct medical and indirect productivity costs. Effective prevention, early diagnosis, and optimal management strategies would significantly reduce these economic loads and improve patient outcomes.
- Open Access
- 19 December 2024
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 62 (6) , 395-397
Topical cyclosporine A in the management of dry eye disease in Sjögren’s syndrome
- 19 December 2024
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 62 (6) , 395-397
Open AccessTopical cyclosporine A in the management of dry eye disease in Sjögren’s syndrome
- Open Access
- 22 November 2024
- Published by Springer Nature in Ophthalmology and Therapy
- Vol. 14 (1) , 153-167
One-Year Comparison of Efficacy and Safety of PreserFlo MicroShunt with Mitomycin C Applied by Sub-Tenon Injection Versus Sponge
Introduction This study was performed to compare the efficacy and safety of PreserFlo MicroShunt (PMS) implantation with mitomycin C (MMC) applied by sub-tenon injection versus conventional application by MMC-soaked sponges. Methods This retrospective, 1-year cohort study included 100 eyes of 100 patients with glaucoma who underwent PMS implantation with MMC (0.4 mg/ml) delivered either by sub-tenon injection (50 eyes) or via soaked sponges (50 eyes). The primary outcome measure at 1 year was intraocular pressure (IOP) reduction, with complete success defined as an IOP reduction of ≥ 20% and achieving a target IOP of ≤ 21 or 18 mmHg without the use of medication. Secondary outcomes, including corneal endothelial cell density (CECD) loss, the number of medications, and complications, were assessed and compared between the groups. Results Sustained reductions in mean IOP were observed in both groups over the 1-year follow-up, with no significant differences between the groups. The complete success rate, with a target IOP of ≤ 21 mmHg after 1 year, was 19.3% in the sponge group and 26.4% in the injection group. The qualified success rate was 59.0% and 87.4% in the sponge and injection groups, respectively. A longer survival rate was observed in the injection group than in the sponge group when IOP was below 21 mmHg. The mean CECD significantly decreased (P < 0.01) from baseline to each postoperative follow-up time point in both groups. At 1 year postoperatively, the percentage of total CECD loss was 8.1% in the sponge group and 8.0% in the injection group. However, no significant differences in mean CECD values, the number of medications, or adverse events were found between the groups. Conclusions PMS implantation with sub-tenon injection of MMC was comparable in terms of efficacy and safety to traditional MMC delivery via soaked sponges. However, the injection group demonstrated a significantly higher success rate than the sponge group.
- 22 November 2024
- Published by Springer Nature in Ophthalmology and Therapy
- Vol. 14 (1) , 153-167
Open AccessOne-Year Comparison of Efficacy and Safety of PreserFlo MicroShunt with Mitomycin C Applied by Sub-Tenon Injection Versus Sponge
Introduction This study was performed to compare the efficacy and safety of PreserFlo MicroShunt (PMS) implantation with mitomycin C (MMC) applied by sub-tenon injection versus conventional application by MMC-soaked sponges. Methods This retrospective, 1-year cohort study included 100 eyes of 100 patients with glaucoma who underwent PMS implantation with MMC (0.4 mg/ml) delivered either by sub-tenon injection (50 eyes) or via soaked sponges (50 eyes). The primary outcome measure at 1 year was intraocular pressure (IOP) reduction, with complete success defined as an IOP reduction of ≥ 20% and achieving a target IOP of ≤ 21 or 18 mmHg without the use of medication. Secondary outcomes, including corneal endothelial cell density (CECD) loss, the number of medications, and complications, were assessed and compared between the groups. Results Sustained reductions in mean IOP were observed in both groups over the 1-year follow-up, with no significant differences between the groups. The complete success rate, with a target IOP of ≤ 21 mmHg after 1 year, was 19.3% in the sponge group and 26.4% in the injection group. The qualified success rate was 59.0% and 87.4% in the sponge and injection groups, respectively. A longer survival rate was observed in the injection group than in the sponge group when IOP was below 21 mmHg. The mean CECD significantly decreased (P < 0.01) from baseline to each postoperative follow-up time point in both groups. At 1 year postoperatively, the percentage of total CECD loss was 8.1% in the sponge group and 8.0% in the injection group. However, no significant differences in mean CECD values, the number of medications, or adverse events were found between the groups. Conclusions PMS implantation with sub-tenon injection of MMC was comparable in terms of efficacy and safety to traditional MMC delivery via soaked sponges. However, the injection group demonstrated a significantly higher success rate than the sponge group.
- Open Access
- 1 December 2023
- Published by Walter de Gruyter GmbH in Journal of Electrical Engineering
- Vol. 74 (6) , 513-520
Unexpected corneal reflection phenomenon alters smartphone 3D image-based models of the eye
Reconstruction of a 3D eye model by photogrammetry from a smartphone video could be prospectively used in self-diagnosis, screening and telemedicine monitoring of diseases of the front part of the eye and its surroundings. The main use could be found in the treatment of diseases of the curvature and surface of the cornea and in follow-up after some refractive procedures. In our work, we create 3D image-based models of the eye after scanning the face with a smartphone. An unexpected phenomenon appeared during the reconstruction of the transparent cornea – a crater-like depression was formed at the place where nearby objects reflected on the cornea, which corresponds to the first Purkinje image, the so-called glint. We thus encountered complications that may arise when modelling transparent living structures from a video taken in a normal environment, which will need to be solved if we want to create such 3D models of the eye using this method for medical purposes. Another 3D reconstruction approach or additional algorithms must be considered as a future work.
- 1 December 2023
- Published by Walter de Gruyter GmbH in Journal of Electrical Engineering
- Vol. 74 (6) , 513-520
Open AccessUnexpected corneal reflection phenomenon alters smartphone 3D image-based models of the eye
Reconstruction of a 3D eye model by photogrammetry from a smartphone video could be prospectively used in self-diagnosis, screening and telemedicine monitoring of diseases of the front part of the eye and its surroundings. The main use could be found in the treatment of diseases of the curvature and surface of the cornea and in follow-up after some refractive procedures. In our work, we create 3D image-based models of the eye after scanning the face with a smartphone. An unexpected phenomenon appeared during the reconstruction of the transparent cornea – a crater-like depression was formed at the place where nearby objects reflected on the cornea, which corresponds to the first Purkinje image, the so-called glint. We thus encountered complications that may arise when modelling transparent living structures from a video taken in a normal environment, which will need to be solved if we want to create such 3D models of the eye using this method for medical purposes. Another 3D reconstruction approach or additional algorithms must be considered as a future work.
- 6 November 2023
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 49 (3) , 280-282
Xenograft: a suitable treatment of eyelid complications in long-standing necrobiotic xanthogranuloma
A porcine xenograft was successfully used as a temporary biological cover for severe xanthogranulomatous defects of the eyelid. Xenografts were successfully used in both upper and lower eyelid reconstructions. Other surgical techniques or the use of full-thickness skin grafts were not possible.
- 6 November 2023
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 49 (3) , 280-282
Xenograft: a suitable treatment of eyelid complications in long-standing necrobiotic xanthogranuloma
A porcine xenograft was successfully used as a temporary biological cover for severe xanthogranulomatous defects of the eyelid. Xenografts were successfully used in both upper and lower eyelid reconstructions. Other surgical techniques or the use of full-thickness skin grafts were not possible.
- Open Access
- 1 August 2023
- Published by Walter de Gruyter GmbH in Journal of Electrical Engineering
- Vol. 74 (4) , 328-335
Detecting glaucoma from fundus images using ensemble learning
Glaucomatous changes of the optic nerve head could be detected from fundus images. Focusing on optic nerve head appearance, and its difference from healthy images, altogether with the availability of plenty of such images in public fundus image databases, these images are ideal sources for artificial intelligence methods applications. In this work, we used ensemble learning methods and compared them with various single CNN models (VGG-16, ResNet-50, and MobileNet). The models were trained on images from REFUGE public dataset. The average voting ensemble method outperformed all mentioned models with 0.98 accuracy. In the AUC metric, the average voting ensemble method outperformed VGG-16 and MobileNet models, which had significantly weaker performance when used alone. The best results were observed using the ResNet-50 model. These results confirmed the significant potential of ensemble learning in enhancing the overall predictive performance in glaucomatous changes detection, but the overall performance could be negatively affected when models with weaker prediction performance are included.
- 1 August 2023
- Published by Walter de Gruyter GmbH in Journal of Electrical Engineering
- Vol. 74 (4) , 328-335
Open AccessDetecting glaucoma from fundus images using ensemble learning
Glaucomatous changes of the optic nerve head could be detected from fundus images. Focusing on optic nerve head appearance, and its difference from healthy images, altogether with the availability of plenty of such images in public fundus image databases, these images are ideal sources for artificial intelligence methods applications. In this work, we used ensemble learning methods and compared them with various single CNN models (VGG-16, ResNet-50, and MobileNet). The models were trained on images from REFUGE public dataset. The average voting ensemble method outperformed all mentioned models with 0.98 accuracy. In the AUC metric, the average voting ensemble method outperformed VGG-16 and MobileNet models, which had significantly weaker performance when used alone. The best results were observed using the ResNet-50 model. These results confirmed the significant potential of ensemble learning in enhancing the overall predictive performance in glaucomatous changes detection, but the overall performance could be negatively affected when models with weaker prediction performance are included.